Endogenous posterior uveitis.
作者信息
Forrester J V
机构信息
Department of Ophthalmology, University of Aberdeen, Medical School, Foresterhill.
出版信息
Br J Ophthalmol. 1990 Oct;74(10):620-3. doi: 10.1136/bjo.74.10.620.
Abstract
摘要
相似文献
1
Endogenous posterior uveitis.
Br J Ophthalmol. 1990 Oct;74(10):620-3. doi: 10.1136/bjo.74.10.620.
2
Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?
Br J Ophthalmol. 1995 Jan;79(1):81-8. doi: 10.1136/bjo.79.1.81.
3
[Posterior uveitis--clinical forms and experimental models].
Klin Oczna. 1994 Jan;96(1):30-3.
4
Anti-TNF therapies in the management of acute and chronic uveitis.
Cytokine. 2006 Feb 21;33(4):231-7. doi: 10.1016/j.cyto.2005.12.012. Epub 2006 Mar 15.
5
Systemic immunosuppression in the treatment of posterior uveitis.
Int Ophthalmol Clin. 1995 Summer;35(3):107-22. doi: 10.1097/00004397-199503530-00009.
6
Syphilitic posterior uveitis: correlative findings and significance.
Clin Infect Dis. 2001 Jun 15;32(12):1661-73. doi: 10.1086/320766. Epub 2001 May 21.
7
[Posterior uveitis. Part 2: specific disorders].
Klin Monbl Augenheilkd. 2014 May;231(5):555-79. doi: 10.1055/s-0033-1357918. Epub 2014 Apr 24.
8
A bird in the hand.
Br J Ophthalmol. 2002 Dec;86(12):1324-5. doi: 10.1136/bjo.86.12.1324.
9
[Posterior uveitis. Part 1: diagnostics and basic concepts of therapy].
Klin Monbl Augenheilkd. 2014 Apr;231(4):457-69; quiz 470-1. doi: 10.1055/s-0033-1357916. Epub 2014 Apr 25.
10
[DOG and BVA Guideline No. 24b - Noninfectious uveitis posterior].
Klin Monbl Augenheilkd. 2018 Jan;235(1):94-107. doi: 10.1055/s-0043-124499. Epub 2018 Jan 26.
引用本文的文献
1
In vivo multi-modal imaging of experimental autoimmune uveoretinitis in transgenic reporter mice reveals the dynamic nature of inflammatory changes during disease progression.
J Neuroinflammation. 2015 Jan 27;12:17. doi: 10.1186/s12974-015-0235-6.
2
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.
Rheumatology (Oxford). 2009 Apr;48(4):347-54. doi: 10.1093/rheumatology/ken489. Epub 2009 Jan 22.
3
Recent perspectives in ocular drug delivery.
Pharm Res. 2009 May;26(5):1197-216. doi: 10.1007/s11095-008-9694-0. Epub 2008 Aug 29.
4
Control of chemokine production at the blood-retina barrier.
Immunology. 2000 Nov;101(3):426-33. doi: 10.1046/j.0019-2805.2000.01105.x.
5
Management of chronic uveitis.
BMJ. 2000 Feb 26;320(7234):555-8. doi: 10.1136/bmj.320.7234.555.
6
Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A.
Br J Ophthalmol. 1997 Dec;81(12):1107-12. doi: 10.1136/bjo.81.12.1107.
7
Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens.
Br J Ophthalmol. 1993 Mar;77(3):171-5. doi: 10.1136/bjo.77.3.171.
8
The treatment of chronic uveitic macular oedema.
Br J Ophthalmol. 1994 Jan;78(1):1-2. doi: 10.1136/bjo.78.1.1.
9
Oligoclonal activation of CD4+ T lymphocytes in posterior uveitis.
Clin Exp Immunol. 1995 Mar;99(3):412-8. doi: 10.1111/j.1365-2249.1995.tb05566.x.
10
Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?
Br J Ophthalmol. 1995 Jan;79(1):81-8. doi: 10.1136/bjo.79.1.81.
本文引用的文献
1
Cellular immune responsiveness of uveitis patients to retinal S-antigen.
Am J Ophthalmol. 1980 Feb;89(2):173-9. doi: 10.1016/0002-9394(80)90108-7.
2
Autoimmunity and the retina.
Curr Top Eye Res. 1980;2:215-302.
3
Serum antibody levels of uveitis patients to bovine retinal antigens.
Invest Ophthalmol Vis Sci. 1981 Nov;21(5):669-80.
4
S-antigen uveitis in primates. A new model for human disease.
Arch Ophthalmol. 1981 Jun;99(6):1090-2. doi: 10.1001/archopht.1981.03930011090021.
5
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.
J Clin Invest. 1981 Apr;67(4):1228-31. doi: 10.1172/jci110138.
6
S antigen-induced experimental autoimmune uveo-retinitis in rats.
Curr Eye Res. 1981;1(6):327-37. doi: 10.3109/02713688108998359.
7
Sympathetic ophthalmia. Histopathologic and fluorescein angiographic correlation.
Arch Ophthalmol. 1984 Feb;102(2):232-5. doi: 10.1001/archopht.1984.01040030182022.
8
Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents.
Am J Ophthalmol. 1983 Sep;96(3):275-82. doi: 10.1016/s0002-9394(14)77814-6.
9
Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
J Immunol. 1983 Aug;131(2):690-6.
10
Human sympathetic ophthalmia. An analysis of the inflammatory infiltrate by hybridoma-monoclonal antibodies, immunochemistry, and correlative electron microscopy.
Ophthalmology. 1983 Jan;90(1):76-95. doi: 10.1016/s0161-6420(83)34602-9.
Zotero 插件